NCT05642858Recruiting
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Source: ClinicalTrials.gov · Last updated 8 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- First submitted
- 18 Nov 2022
- Start date
- 12 Mar 2023
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- University of California, San Francisco
- Diseases
- HIV
- NCT number
- NCT05642858
What you commit to
- Study type: Interventional
- Planned participants: 260
- From 12 Mar 2023 to the primary completion date, 1 Dec 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Existing clinical atherosclerotic cardiovascular disease (ASCVD)
Other
- Pregnant
- Unwilling/unable to provide informed consent
- Does not own a smartphone
Who the study is looking for
- HIV positive
- At least 40 years of age
- English-speaking
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
| Zuckerberg San Francisco General Hospital Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.